Fool’s School Investing in Biotech (The Philadelphia Inquirer)
Fool’s School Investing in Biotech (The Philadelphia Inquirer)
Some biotechnology companies that are busy developing tomorrow’s blockbuster medications will end up delivering powerful long-term performances. That’s far from a sure thing, though, so look before you leap.